Status:

UNKNOWN

The Effect of Intra-vaginal Conjugated Estrogen Cream on Ring Pessary Use for Pelvic Organ Prolapse

Lead Sponsor:

Peking Union Medical College Hospital

Conditions:

Pelvic Floor Prolapse

Eligibility:

FEMALE

Phase:

PHASE4

Brief Summary

The primary purpose of this two-arm randomized clinical trial is to determine if in women desiring use of a pessary for pelvic organ prolapse (POP) and are successfully fit, if 1-year use and patient ...

Detailed Description

The study is a multi-center, randomized trial of women with symptomatic utero-vaginal or post-hysterectomy vaginal vault prolapse desiring non-surgical treatment with a pessary. This study will compar...

Eligibility Criteria

Inclusion

  • Symptomatic POP, stage II, stage III or stage IV
  • Postmenopausal women (patients with serum FSH\>40lu/L; or amenorrhea for 12 months)
  • Successfully fit with ring with support pessary
  • Ability to attend the clinical trial and follow-up
  • Patients and their families understand the study, are willing to participate for up to 1 year and can provide written informed consent
  • Willing and able to place vaginal cream

Exclusion

  • Acute infection of internal genital tract
  • Hormone replacement therapy in recent 3 months
  • Suspected or untreated lower genital tract tumor
  • Genital fistula
  • Abnormally elevated intra-abdominal pressure (eg ascites, tumor, etc)
  • Life expectancy less than 1 year
  • Vaginal estrogen contraindications, including known or suspected estrogen dependent malignancies (endometrial carcinoma, melanoma), endometrial hyperplasia (thickness of endometrium≥5mm), thrombophlebitis or thromboembolic disease, undiagnosed irregular vaginal bleeding, known or suspected breast cancer, allergy to any component of the estrogen cream and severe liver disease, breast cancer
  • The volume of post-voiding residual is more than 250ml. -

Key Trial Info

Start Date :

May 24 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2022

Estimated Enrollment :

420 Patients enrolled

Trial Details

Trial ID

NCT04393194

Start Date

May 24 2020

End Date

September 1 2022

Last Update

May 19 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.